Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 68.01% vs -0.21% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -22.96% vs 34.67% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -16.96% vs 11.56% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -22.64% vs -23.83% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Vidipha Central Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 59.32% vs 7.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 68.01% vs -0.21% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -4.48% vs -11.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -22.96% vs 34.67% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -1.91% vs -28.49% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -16.96% vs 11.56% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 26.15% vs -0.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -22.64% vs -23.83% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






